Shares of Canopy Growth Corp CGC, a Canada-based cannabis company, surged Wednesday morning after announcing an expansion of a partnership with minority shareholder Constellation Brands, Inc. STZ.
Constellation Brands said it will invest C$5 billion ($4 billion) in Canopy, which would increase its ownership stake to 38 percent. As part of the agreement, Constellation will acquire new shares directly from Canopy at a 37.9-percent premium to Canopy's five-day volume weighted average price on the Toronto Stock Exchange.
Canopy will use the proceeds from the transaction to strategically build and/or acquire key assets to establish a global scale.
The Sector Reacts
The transaction is the largest of its kind to date in the cannabis space and the nearly 40-percent premium paid by Constellation likely supported upside in other cannabis-related names Wednesday morning.
- Canopy Growth was up nearly 40 percent.
- Cronos Group Inc CRON, a company dedicated towards changing and removing negative misconceptions about cannabis, was trading higher by 12 percent.
- Tilray Inc TLRY, a company in engaged in research, cultivation, production and distribution of cannabis, was trading higher by 11 percent.
- ETFMG Alternative Harvest ETF MJ, an index that tracks the performance of companies engaged in legal activities of cannabis for medical or non-medical purposes, was trading higher by 6 percent.
- GW Pharmaceuticals GWPH, a developer of cannabinoid prescription medicines, was trading higher by 1.2 percent. GWPH shares got a boost from Stifel, which initiated coverage on the stock with a Buy rating.
Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference on August 17, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited — get your tickets before they sell out.
Related Links:
The Cannabis Industry's Go-Public Frenzy: A Chat With Companies That IPOed This Year
AxisWire: Cannabis Companies Are Moving To Canada, Its Friendlier Legal Climate
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.